PBYI
NASDAQ
US
Puma Biotechnology Inc - Common Stock
$6.90
▲ +$0.14
(+2.07%)
Vol 347K
11
Quality Score
ok
Deep Check
1/5
fail
Rev ✗
NI ✓
>IPO ✗
Mkt Cap
$299.8M
P/E
8.1
ROE
36.1%
Margin
17.4%
D/E
29.25
Beta
1.25
52W
$3–$6
Wall Street Consensus
6 analysts · Apr 20260
Strong Buy
0
Buy
3
Hold
1
Sell
2
Strong Sell
0.0%
Buy Rating
Price Chart
Similar Stocks
MNPR
Monopar Therapeutics Inc
$436.4M
CADL
Candel Therapeutics Inc
$310.2M
IVVD
Invivyd Inc
$684.5M
IMRX
Immuneering Corp
$424.9M
DMAC
DiaMedica Therapeutics Inc
$414.5M
CABA
Cabaletta Bio Inc
$210.8M
XOMA
Xoma Royalty Corp
P/E 15.2
$329.3M
IRD
Opus Genetics Inc
$138.6M
XFOR
X4 Pharmaceuticals Inc
$349.7M
Earnings
Beat rate: 100.0%| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Dec 2025 | $0.23 | $0.26 | +$0.03 |
| Sep 2025 | $0.05 | $0.17 | +$0.12 |
| Jun 2025 | $0.10 | $0.12 | +$0.02 |
| Mar 2025 | $-0.02 | $0.06 | +$0.08 |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | 53.1% | 53.1% | 53.1% | 53.1% | 36.1% | 36.1% |
| P/E (TTM) | 3.51 | 5.37 | 5.41 | 5.30 | 6.64 | 8.11 |
| Net Margin | 11.2% | 20.4% | 20.4% | 20.4% | 17.4% | 17.4% |
| Gross Margin | 76.5% | 72.3% | 72.3% | 72.3% | 76.9% | 76.9% |
| D/E Ratio | 42.84 | 42.84 | 42.84 | 42.84 | 29.25 | 29.25 |
| Current Ratio | 1.73 | 1.73 | 1.73 | 1.73 | 1.74 | 1.74 |
Key Ratios
ROA (TTM)
18.3%
P/S (TTM)
1.41
P/B
1.6
EPS (TTM)
$0.74
CF/Share
$0.31
Rev Growth 3Y
-3.1%
52W High
$6.22
52W Low
$2.58
$2.58
52-Week Range
$6.22
How does PBYI compare to Biotechnology peers?
Peer group: Micro-cap Biotechnology (All) · 528 companies
PBYI valuation vs Biotechnology peers
P/E ratio
8.1
▼
57%
below
peers
(18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
1.4
▼
89%
below
peers
(12.9)
vs Peers
vs Industry
Undervalued
P/B ratio
1.6
▼
34%
below
peers
(2.5)
vs Peers
vs Industry
Pricier
Div yield
—
▼
0%
below
peers
(0.0%)
vs Peers
vs Industry
Low yield
PBYI profitability vs Biotechnology peers
ROE
36.1%
▲
154%
above
peers
(-67.3%)
vs Peers
vs Industry
Top tier
Net margin
17.4%
▲
106%
above
peers
(-286.8%)
vs Peers
vs Industry
Below avg
Gross margin
76.9%
▼
2%
below
peers
(78.6%)
vs Peers
vs Industry
Weak
ROA
18.3%
▲
139%
above
peers
(-46.7%)
vs Peers
vs Industry
Top tier
PBYI financial health vs Biotechnology peers
D/E ratio
29.3
▼
0%
below
peers
(0.0)
vs Peers
vs Industry
High debt
Current ratio
1.7
▼
61%
below
peers
(4.4)
vs Peers
vs Industry
Low liquidity
Beta
1.3
▲
29%
above
peers
(1.0)
vs Peers
vs Industry
More volatile
PBYI fundamentals radar
PBYI
Peer median
Industry
PBYI profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
PBYI vs peers: key metrics
Latest News
No related news yet